Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: January 2019

1/31/2019 Database Update: Import of Pharmaceutical Drugs Made in EEU Countries to Russia (December 2018)

Between January and December 2018, Russia imported 9.4 bln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale prices, VAT included), which is in monetary terms 13.1% higher than that of the same period in 2017. The dynamics in physical terms are only +0.9%. The total import volume from Belarus, Kazakhstan, and Armenia amounts to 213.6 mln units.

1/25/2019 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (December 2018)

Unfortunately, 2018 was not a profitable year for Russian pharmaceutical production. In 2018, Russia produced 336 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms only 0.7% higher than that of 2017. These dynamics is the lowest since 2015. In physical terms, the dynamics are -5.3% (4.3 bln units of pharmaceuticals.)

1/22/2019 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (November 2018)

Between January and November 2018, Russia imported 58.5 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 11.4% higher than that of the same period of 2017. The dynamics of the import of feed supplements in monetary terms are the highest, +11% (33.5 bln RUB), followed by veterinary drugs (+12.2%, 23.3 bln RUB) and veterinary APIs (+8.9%, 1.7 bln RUB.)

1/21/2019 Database Update: API Import to Russia (November 2018)

Between January and November 2018, Russia imported 86.7 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 29.3% lower than that of the same period of 2017. In physical terms, Russia imported 10,600 tons of APIs, which is 5% lower than that of the same period of 2017.

1/21/2019 Database Update: Pharmaceutical Drug Import to Russia (November 2018)

Between January and November 2018, Russia imported 475.3 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices, VAT included), which is in monetary terms 0.5% higher than that of the same period of 2017, and 97.3 bln RUB worth of in-bulk drugs, which is 13.6% higher than that of the same period of 2017. The total dynamics in monetary terms are +2.5%.

1/16/2019 Database Update: Pharmaceutical Drug Export from Russia (September 2018)

Between January and September 2018, Russia exported 16.1 bln RUB worth of pharmaceutical drugs (EEU countries excluded, customs duties included), which is in monetary terms 9.3% higher than that of the same period of 2017. In physical terms, the export volume is 0.37 bln units and the dynamics are -6%. If calculated in minimum dosage units (MDU), the dynamics are also negative, -9.4%.